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ABSTRACT
Microfocus CT (micro-CT) has traditionally been used in industry and preclinical studies, although it may find new
applicability in the routine clinical setting. It can provide high-resolution three-dimensional digital imaging data sets to the
same level of detail as microscopic examination without the need for tissue dissection. Micro-CT is already enabling non-
invasive detailed internal assessment of various tissue specimens, particularly in breast imaging and early gestational fetal
autopsy, not previously possible from more conventional modalities such as MRI or CT. In this review, we discuss the
technical aspects behind micro-CT image acquisition, how early work with small animal studies have informed our
knowledge of human disease and the imaging performed so far on human tissue specimens. We conclude with potential
future clinical applications of this novel and emerging technique.
INTRODUCTION
Since the inception of CT in the 1970s, the diagnosis and
treatment pathways of many medical conditions have been
revolutionized.1 Whilst current state-of-the art CT scanners
can image structures down to a voxel size of 1mm3, the
need for higher resolution imaging for smaller specimens
led to the ﬁrst microfocus CT (micro-CT) scanners being
developed in the 1980s.2
Over the subsequent decades, micro-CT imaging technol-
ogy has advanced considerably with current scanners able
to achieve sub-micron voxel-level resolution. The in-
creasing availability and usage of this technique in modern
science is reﬂected by the rising number of publications on
the topic.3 This has been predominantly due to work in
small animal studies which include phenotyping,4–6 bone
morphology analysis7 and plant biology.8
Micro-CT has also been used extensively in industry for
non-destructive precision engineering, particularly where
strict tolerances are required, or where performance of a part
is vital to the safe function of a system (e.g. aircraft engine
turbine blade inspection).9 It also plays an important role in
archaeology, where historical artefacts can be analyzed and
“virtually dissected” to investigate their contents, thereby
minimizing disruption and degradation due to handling.10
Owing to the requirement for relatively long scan times
(which can range between 8min and 3h depending on res-
olution and image quality) and need to mechanically stabilize
the object being scanned, micro-CT is not yet widely utilized
in clinical investigations. Nevertheless, this may change as
technology advances, knowledge of the technique develops
and costs of scanner manufacture and maintenance reduce.
The objectives of this review article are to introduce readers
to the principles of this novel imaging technique, how it
has been utilized for preclinical usage to date and where
this modality may beneﬁt medical practice in the future.
Technical aspects
Micro-CT scanners work in a similar manner to medical CT
scanners, in that both methods rely on an X-ray beam to
irradiate the object of interest and photosensitive detectors
record the unabsorbed photon signals to produce an in-
terpretable three-dimensional (3D) data set after software
post-processing techniques are applied (e.g.modiﬁed ﬁltered
back projection).
Two main construction designs principles are in existence
(Figure 1). The ﬁrst (sometimes termed “minifocus CT”) is
an identical setup to medical CT scanners with the X-ray
detection source and detectors mounted on a rotating gantry
around the object being examined. In these systems, there is nor-
mally a ﬁxed “radiation source-to-detector” distance which limits
the resolution capabilities (approximate range of 50–100 micron
voxels). In the second design (used for industrial applications and
most ex vivo specimens) (Figure 2) the radiation source is ﬁxed,
with the object of interest mounted on an adjustable, rotating
platform during the examination. The advantage of this is that this
allows for the adjustment of the “radiation source-to-object” and
“object-to-detector” distance, giving improved resolution (less than
1 micron voxels achievable). Resolution comparable with high-
power histology can be achieved with adequate magniﬁcation.
There is also the additional beneﬁt of an isotropic 3D data set that
does not require dissection of the specimen or labour-intensive
practices, which would be necessary for high-resolution episcopic
microscopy and episcopic ﬂuorescence image capture.
Microfocus CT contrast media
As soft tissue demonstrates minimal inherent X-ray attenuation,
many micro-CT studies utilize either immersion of the tissues in
exogenous contrast or long exposure times and frame averaging
in order to differentiate between tissues and tissue substructures.
Proposed tissue contrast agents for use with micro-CT include
iodine preparations [including Lugol’s solution/I2KI, elemental
iodine dissolved in ethanol or methanol (I2E/I2M) and potas-
sium iodide], phosphotungstic acid, phosphomolybdic acid,
osmium tetroxide and other metal-based compounds (e.g.
mercuric chloride, silver nitrate).4,5,11 Contrast agents vary
widely in their tissue speciﬁcity, cost, toxicity and effect on the
subsequent production of histology preparations; therefore, the
choice of tissue contrast is a key consideration.
Other silicone based compounds that solidify following injection
into the vascular system and addition of a curing agent may be
used for angiographic investigations. When appropriately used,
a contrast agent may allow for shorter scans with better iden-
tiﬁcation of differential densities from target tissues. Non-
contrast (unenhanced) scans can also provide excellent results,
even in low-density tissues such a lung and skin.12–14 As
parafﬁn-embedded tissue samples are mechanically stable and
not amenable to immersion in an exogenous agent, they are also
well suited to non-contrast techniques.
Where larger structures (such as human fetuses) are examined,
the variety of different tissue types within the structure greatly
beneﬁt from contrast emersion and provide excellent differen-
tiation of internal viscera currently below the level offered by
post-mortem CT and MRI. Initial proof of principle has been
demonstrated,15,16 although technical considerations and di-
agnostic accuracy remain to be addressed.
EVALUATION OF MICROFOCUS CT FOR
ANIMAL TISSUE
Advances in genetic engineering have resulted in multiple ani-
mal models of human diseases, particularly in drug de-
velopment, treatment and the pre-clinical understanding of
disease manifestations. Recent optimization of contrast agent
development and administration now permit vessel morphology
and soft tissue structures in vivo to be evaluated.17 Nevertheless,
ex vivo animal imaging still confers certain advantages over
in vivo imaging, particularly increased resolution, partly from
longer scan times (which can take up to 2–3 h for a highly
detailed study) and increased photon ﬂux without the
Figure 1. Microfocus (micro-CT) machine construction principles: (a) a “mini-focus” CT design and a (b) typical micro-CT used for
industrial imaging and preclinical research are demonstrated. The mini-focus CT design is similar to that of a medical CT scanner,
whereas in the second design the object is being rotated and different parameters such as “source-to-object” and “object-to-
detector” distances are adjustable allowing for greater magnification and resolution of the resultant image.
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consideration of anaesthetic requirements, cardiac gating or
increased radiation dosage.18 Here, we review the use of micro-
CT imaging in animal models and highlight how information
acquired may be translated into the understanding and treat-
ment of human diseases.
Neurological
Several ex vivo studies have provided detailed cerebral vascular
anatomy,19 estimation of cerebral blood volume and detection of
atherosclerotic lesions in the mouse brain.20 More recently,
in vivo techniques have allowed imaging of blood–brain barrier
dysfunction in mice post-stroke21 and micropositron emission
tomography/CT imaging has proved to be a feasible technique in
longitudinal assessment of brain tumour growth and treatment
response in mice.22 Industrial micro-CT machines have also
been modiﬁed to produce targeted high radiation doses for ra-
diotherapy in mouse models with glioblastoma implants.23
These models to assess and quantify diseases and improvements
with novel therapies have the potential for translation into hu-
man trials.
Chest and cardiac
Ex vivo rat and rabbit heart imaging with contrast-enhanced
micro-CT have characterized the 3D cardiac conduction system
which has the potential to direct surgical treatment planning for
congenital heart disease and cardiac ablation procedures.24
Micro-CT imaging and models could be useful in educating
surgeons and cardiologists in interventional cardiac techniques
when training on animal models, prior to independently in-
tervening on live patients.
Diagnostic accuracy of micro-CT for the detection of congenital
heart disease in mice is almost 90% when compared with his-
tology25 and micro-CT of human ex vivo hearts would improve
our understanding of cardiac structure and anatomy, particu-
larly in the less invasive perinatal autopsy setting.
Automated micro-CT software has been used to quantify aerated
lung volumes in an in vivo mouse model of bleomycin-induced
pulmonary ﬁbrosis with good repeatability and potential for
drug studies,26 and also to demonstrate tumour progression and
response to experimental therapy in a mouse model of lung
cancer.27 These assessments of treatment response may again
help to develop novel therapies translatable to humans.
Abdominal
Models mimicking colonic carcinoma in mice have shown
a high correlation between identiﬁed tumour volume and his-
tology28 on micro-CT colonography. If this is translatable in
human diseases, the imaging and assessment of surgical speci-
mens with micro-CTalone may remove the need for histological
dissection of the specimen.
The use of liver-speciﬁc iodinated contrast agents in vivo in mice
models has also allowed for delineation between healthy “en-
hancing” hepatocytes and unenhancing neoplastic lesions (as
small as 100mm), thereby allowing quantiﬁcation of liver
metastases,29,30 and changes in size and number with experi-
mental drug trials. Detailed 3D illustrations of the murine liver
for research anatomical reference31 has also been described to
assist animal researchers in determining the vascular supply to
Figure 2. Inside a microfocus CT machine: the radiation source (X-ray gun), rotating platform (with specimen pot mounted) and
detector are visible to the operator and labelled accordingly. All of these components are housed within a radiation-shielding
cabinet made of lead and steel, which means there is no need for additional lead shielding when using the machinery, nor for it to be
placed in a specialized lead-lined room.
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the liver and potential hepatic lesions. This enables accurate
assessment of tumour spread and relapse in models of disease
and thereby identiﬁcation of treatment failure.
Musculoskeletal and soft tissue
Numerous articles have investigated the effects of bone structure,
osteogenesis, osteoporosis, bone resorption, bone remodelling,
fracture healing, neoplasms and biocompatible materials,3,7,32,33
within various animal models. The ability of micro-CT to evaluate
trabecular structures allows quantiﬁcation of bone destruction,
commonly assessed in drug treatments and oncological pro-
gression.34 Mouse models with osteogenesis imperfecta have
demonstrated improved bone architecture with haematopoietic
stem cell transplant therapy35 and characterization of osseous
tumour inﬁltration have been combined with bioluminescence
imaging techniques in prostate cancer mouse models in vivo to
better assess tumour growth and response.19,36 There are few
studies of micro-CT assessment of muscle ﬁbre characterization
and disease, although its feasibility and beneﬁts over diffusion
tensor imaging have been reported.37
Micro-CT has been used to test the effectiveness of uptake of
implant materials within muscle tissue “dead space” post-
debridement in mice.38 This information can be used to inform
the degree of soft tissue compatibility with various prosthetic
and surgical materials. Other animal studies using micro-CT to
characterize changes in muscle angiogenesis and fatty muscle
inﬁltration post-distraction osteogenesis39 and muscle tenot-
omy,40 respectively, could interest orthopaedic surgeons and
rheumatologists on potential post-operative processes occurring
in their patients.
Genetic diseases
Early research has shown that micro-CT imaging of embryonic
mice analyzed with autorecognition software can help segment
various organs to build a database of standard organ dimensions
for embryonic development. As there is 99% homology between
mice and humans, researchers hope that different mutated
mouse lines can be imaged and organ volumes evaluated to
enable better understanding of the contributory role each gene
plays in different organ development. This may have implica-
tions for prognosis when identifying human genetic disorders
in utero.41
EVALUATION OF MICROFOCUS CT FOR
HUMAN TISSUE
Phenotyping of human disease using micro-CT is less well
established than in animal models, although these techniques
are gaining popularity and could offer new insights into human
pathology.
Neurological
One ex vivo study has demonstrated the ability of micro-CT to
identify various cellular constituents of adamantinomatous
craniopharyngioma tumours within brain tissue, based on grey
levels (Figure 3). Post-processing volumes allowed the complex
3D relationships of the tumour to be demonstrated within the
background brain tissue at isotropic voxel sizes of 4–6
microns.42 Subsequent histological processing and staining was
not affected by iodine-enhanced micro-CT examination, which
is encouraging for wider application of histological validation of
micro-CT ﬁndings.
Chest and cardiac
Two studies examining the use of micro-CT for human fetal ex
vivo hearts show that iodine-enhanced micro-CT can provide
highly accurate 3D renderings of a variety of complex congenital
heart diseases, without the need for injection of contrast agents
and detailed tissue dissection. Initial diagnostic accuracy data
suggest that in isolated human fetal hearts (or heart and lung
blocks) extracted at autopsy, micro-CT has .95% concordance
with full autopsy for anatomical features, with no apparent
discrepancies in overall diagnosis between micro-CT and full
autopsy in these feasibility studies (Figure 4).15,43–45
The potential for 3D data sets to enhance traditional histopa-
thology methods is also demonstrated in studies that used
non-contrast micro-CT to examine lung tissues. Scott et al12
demonstrate 3D modelling of small airways and blood vessels
within formalin-ﬁxed parafﬁn-embedded lung tissue that could
potentially be interrogated by a morphometric approach for
investigation of disease processes (Figure 5).
Further to this work, features of lung pathology, such as ﬁbro-
blastic foci, which are important diagnostic features of some
interstitial lung diseases, have been identiﬁed on micro-CT ex-
amination of formalin-ﬁxed parafﬁn-embedded lung tissue and
their 3D relationships interrogated. Jones et al14 demonstrated
no evidence of interconnectivity between ﬁbroblastic foci in
samples taken from patients with idiopathic pulmonary ﬁbrosis,
consistent with the current concept that ﬁbroblastic foci repre-
sent discrete sites of repair following lung injury. Applying
a similar morphometric approach to explanted frozen lung tis-
sue, loss of pre-terminal and terminal bronchioles in patients
with lung allograft dysfunction has also been identiﬁed using
micro-CT and veriﬁed using comparative histology.46 Further
analysis of frozen lungs explanted from patients with cystic ﬁ-
brosis has yielded detailed information of end-stage cystic ﬁ-
brosis disease showing dilatation and obstruction of nearly all
airway generations down to the terminal bronchioles.47
Abdominal
There are little data regarding micro-CT imaging of human intra-
abdominal viscera, with the majority of studies available relating
to the kidney. One case report48 has demonstrated normal micro-
CT renal anatomy at autopsy in a term neonate, with resolution
comparable with that of low-power histology. In a case of known
cystic kidney disease, radially arranged, elongated cysts could be
readily deﬁned from the micro-CT data, allowing the diagnosis for
autosomal recessive polycystic kidney disease to be made. Imaging
of a multicystic dysplastic kidney revealed cysts of varying sizes
with histological conﬁrmation. Another study demonstrated im-
aging of lower urinary tract obstruction using contrast-enhanced
micro-CT.49 Cystic kidney disorders have variable inheritance
patterns, with a wide variation in recurrence risk. With further
optimization, micro-CT may be able to provide a non-invasive,
permanent record of disease phenotype in such cases without the
need for a full autopsy.
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Musculoskeletal and soft tissue
The majority of published micro-CTwork in humans relating to
the bone has thus far focused on maxillofacial and dental
surgery-related topics. These have included assessments of
dental and mandibular morphology,50 and bone quality at dental
implant sites.51 Outside of dentistry, human cadaveric cochleae
have been examined with both micro-CT and synchrotron im-
aging to create 3D anatomical models which may inform co-
chlear implant surgery in the future.52 Another recent study
assessed bone cores from 68 paediatric patients with end-stage
renal failure using micro-CT. The imaging ﬁndings allowed the
researchers to accurately measure bone volume and quantify the
inverse relationship between osteoid accumulation at bone his-
tomorphometry and bone mineral density from micro-CT
measurements.53
With regard to soft tissue ﬁndings, the most exciting work in
humans has related to breast imaging studies. Tang et al54–56 have
used micro-CT to assess intraoperative breast lumpectomy speci-
mens to give their surgical colleagues real-time analysis and in-
formation on tumour margins. More recent work has shown that
breast cancer specimen T-stage assignment by micro-CT analysis
only differed in 15.2% of cases when compared with histological
analysis; in addition, there was a strong agreement between tu-
mour size and stage for invasive ductal carcinoma between the two
techniques, although not for invasive lobular carcinoma.57
Human autopsy
The combination of improved ultrasound screening and non-
invasive prenatal testing means that decisions regarding the
management of pregnancies are more commonly made at the
end of the ﬁrst trimester, when fetuses are usually too small for
diagnostic examination using 1.5-T MRI.58
Lombardi et al15 have demonstrated proof of principle of the use
of iodine-enhanced micro-CT in human fetal autopsy between
the ages of 7–17 gestational weeks (Figure 6). The opportunity
to use micro-CT for whole-body early-gestation fetal autopsy
represents a novel imaging tool in these cases, to conﬁrm or
refute diagnoses leading to termination of pregnancy.16 In ad-
dition, these ﬁndings demonstrate the potential of micro-CT for
detailed PM imaging of entire fetuses whilst maintaining tissue
integrity, with signiﬁcant implications for perinatal autopsy
practice. 3D imaging data sets generated by micro-CT provide
a permanent record of ﬁndings that can be virtually dissected
and discussed with the clinical team.
Figure 3. Microfocus CT imaging of human adamantinomatous craniopharyngioma (ACP): (a) virtual and matched histological
tissue section of an ACP showing areas of tumour interspersed by reactive glial tissue. Scale bar indicates 1mm. (b) 203 images of
specific tumour compartments from boxed regions of (a). The left panel shows epithelial whorls (“clusters”) within an area of
tumour and the right panel shows “wet keratin” (WK) which has a higher grey value on CT imaging. Scale bars indicate 100mm. EW,
epithelial whorls; G, reactive glial tissue; PE, palisading epithelium; SR, stellate reticulum. Figure adapted from Apps et al42 under the
Creative Commons Attribution License 4.0.
Figure 4. Microfocus CT volume rendering of a heart and lung
block from an 18-gestational week fetus with hypoplastic right
heart syndrome: transposition of the great arteries and
a ventriculoseptal defect (VSD) can be visualized. Adapted
from Hutchinson et al45 with permission.
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Forensic applications
Micro-CT also has an emerging role in the forensic investigation
of deaths, where utility has been demonstrated across a wide
range of applications, including non-destructive phenotyping of
bony injuries59,60 to match wounds with potential instruments.
Use of micro-CT to assist entomological investigations could
potentially assist in estimating a minimum post-mortem death
interval through the features of blowﬂy larvae present on
a body.61 Features of tooth development could also potentially
be assessed to assist with age estimation. Cecchetto et al62,63 have
also demonstrated the use of micro-CT to examine gunshot
residue and wounds in various forensic scenarios.64
In one interesting case, Fais et al65 describe a situation where
micro-CT demonstration of subtle laryngeal fractures and intra-
cartilaginous laryngeal haemorrhages (not seen on conventional
multislice CT imaging or evidenced by visual external examina-
tion) allowed conﬁrmation of fatal manual strangulation as mode
of death where the perpetrators confession was deemed unreliable
in court owing to mental illness. However, this is an exceptional
situation, and the use of novel imaging techniques in court should
be approached with caution prior to rigorous and sound scientiﬁc
merit on accuracy of the procedure.
LIMITATIONS OF MICRO-CT
Several issues remain to be addressed for widespread imple-
mentation of micro-CTscanning of complete early human fetuses.
These include, but are not limited to, the cost of the procedure
and equipment (including processes for reimbursement), the
effects of tissue colouration and distortion due to the ﬁxation and
contrasting processes, the current need for a skilled operator
to acquire, reconstruct and process the images and data stor-
age requirements in orders of magnitude greater than con-
ventional clinical scans (this typically ranges from 10 to 30 GB
per case).
Some of the reported human fetal studies have used eviscerated
organs in cases undergoing full standard autopsy as proof of
principle, whereas a true non-invasive or less-invasive autopsy
would involve whole-body in situ organ imaging. Further studies
will be needed to optimize tissue preparation as well as image
acquisition in a variety of clinical settings, prior to compre-
hensive formal diagnostic accuracy evaluations against both
existing imaging and pathology techniques.
FUTURE DIRECTIONS
Once the use of micro-CT becomes cheaper and more wide-
spread, the potential for clinical applications are far reaching and
promising for educational, diagnostic and therapeutic moni-
toring purposes.
In research, preparing and analyzing micro-CT images alongside
traditional histopathological laboratory techniques has shown
excellent agreement. This allows for a standardized and re-
producible methodology, with the added beneﬁt of revisiting the
digital imaging data by other researchers, remotely if desired. It
could improve consistency between multicentre study results, as
prior studies of histological specimens have reported different
preparation techniques between laboratories limiting the gen-
eralizability of ﬁndings.
Figure 5. Matched serial microfocus CT (micro-CT) and Movat’s pentachrome-stained histological sections: serial micro-CT images
(a–d) and corresponding Movat’s pentachrome-stained histological sections (e–h) demonstrate the ability of micro-CT to provide
sufficient contrast between tissue and paraffin to allow image analysis. RB, respiratory bronchiole; TB, terminal bronchiole. Adapted
from Scott et al12 in accordance with the Creative Commons Attribution License 4.0.
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Building on this knowledge, micro-CT analysis can be imple-
mented in routine clinical work where imaging of intraoperative
surgical specimens (such as in the study described for breast
specimens) may inform surgical resection margins in real time.
This intraoperative approach can be postulated to be useful in
other contexts, such as children undergoing nephron-sparing
surgery for Wilms tumour resection. Accurate differentiation of
tumour constituents within an excised tumour specimen may be
possible by adapting the techniques described in human pitui-
tary tumour specimens, facilitating more detailed or speciﬁc
tumour characterization. Analysis of tumour angiogenesis and
invasion can also be reviewed in surgical specimens following
resection without the need for complex staining techniques to
provide information of spread and treatment effects (for ex-
ample in brain tumours). Micro-CT imaging offers the added
advantage over specimen dissection of virtual slicing of the tissue
in any plane and providing 3D relationships of different tissue
compartments.
Future optimization and development of in vivo micro-CT
machines may make it feasible to replace invasive methods of
assessing bone microarchitecture, such as bone histo-
morphometry, which relies on obtaining a bone biopsy. Micro-
CT may help differentiate different bone pathologies based on
trabeculation and bone mineralization densities and could
monitor the effects of treatment from metabolic bone diseases
(such as changes with bisphosphonate therapy). Nevertheless,
this would still require more reﬁnement of the technique, and
studies are yet to show that micro-CT can differentiate pathol-
ogy from normal bone samples in humans.
CONCLUSION
Micro-CT is an established animal and industrial imaging
technique which is now being evaluated in the human setting,
with early reports of diagnostic evaluation. Micro-CT has the
potential to provide a step-change improvement in diagnostic
imaging of small clinical specimens, with near histological levels
of detail. As a non-destructive imaging modality, videos and 3D
images can be easily stored, re-examined and transferred to
specialists for diagnostic opinions, unlike current histological
evaluations. The combination of high anatomical detail, rela-
tively short scan times and computer-aided dissection could put
micro-CTat the centre of human fetal autopsy examinations and
surgical specimen imaging in the future.
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